S-100β does not predict outcome after mild traumatic brain injury

Brain Injury

Volumn 28, Issue 11, 2014, Pages 1430-1435

  Ryb, Gabriel E ^a,b,c   Dischinger, Patricia C ^a   Auman, Kimberly M ^a   Kufera, Joseph A ^a   Cooper, Carnell C ^b,c   Mackenzie, Colin F ^a   Kane, Robert L ^b  

^a National Study Center for Trauma and Emergency Medical Systems   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c Prince Georges Hospital Center   (United States)

Author keywords

Biomarker; Mild TBI; Post concussive syndrome; S 100 ; Traumatic brain injury

Indexed keywords

BIOLOGICAL MARKER; PROTEIN S100B;

ADULT; AMNESIA; ARTICLE; CHECKLIST; COMPUTER ASSISTED TOMOGRAPHY; CONCUSSION SYMPTOM CHECKLIST; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENDER; HOSPITAL ADMISSION; HUMAN; INJURY SEVERITY; MAJOR CLINICAL STUDY; MALE; MULTIPLE TRAUMA; NEUROIMAGING; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PRE INJURY SYMPTOM; PROTEIN BLOOD LEVEL; RETURN TO WORK; RETURN TO WORK OR SCHOOL; SCHOOL; SEIZURE; SYMPTOMATOLOGY; TRAUMATIC BRAIN INJURY; ADOLESCENT; BLOOD; BRAIN INJURIES; CENTRAL NERVOUS SYSTEM DISEASES; INJURY SCALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROGNOSIS; REPRODUCIBILITY; UNITED STATES;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BRAIN INJURIES; CENTRAL NERVOUS SYSTEM DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INJURY SEVERITY SCORE; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; RETURN TO WORK; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT; UNITED STATES;

EID: 84907045808     PISSN: 02699052     EISSN: 1362301X     Source Type: Journal    
DOI: 10.3109/02699052.2014.919525     Document Type: Article

References (34)

1. Faul M, Xu L, Corn ado VG. Traumatic brain injury in the United States: emergency department visits, hospitalizations and deaths 2002- 2006. Atlanta, GA: Centers for Disease Control and Prevention; 2010.
2. National Center for Injury Prevention and Control. Report to congress on mild traumatic brain injury in the United States: Steps to prevent a serious public health problem. Atlanta, GA: Centers for Disease Control and Prevention; 2003.
3. Thurman DJ. The epidemiology and economics of head trauma. In: Miller L, Hayes R, editors. Head trauma: Basic, preclinical and clinical directions. New York: John Wiley and Sons; 2001.
4. Thurman DJ, Alverson C, Dunn KA, Guerrero J, Sniezek JE. Traumatic brain injury in the United States: A public health perspective. Journal of Head Trauma Rehabilitation 1999;14: 602-615.
5. Rees PM. Contemporary i ssues in mild traumatic brain injury. Archives of Physical Medicine & Rehabilitation 2003;84: 1885-1894.
6. Bottiger BW,Mobes S,Glatzer R,Bauer H,Gries A,Bartsch P,Motsch J,Martin E. Astroglial protein S-100 is an early and sensitive marker of hypoxic brain damage and outcome after cardiac arrest in humans. Circulation 2001;103:2694-2698.
7. Herrmann M, Curio N, Jost S, Grubich C, Ebert AD, Fork ML, Synowitz H. Release of biochemical markers of damage to neuronal and glial brain tissue is associated with short and long term neuropsychological outcome after traumatic brain injury. Journal of Neu rology, Neurosurgery & Psychiatry 2001;70:95-100.
8. Muller K, Townend W, Biasca N, Unden J, Waterloo K, Romner B, Ingebritsen T. S100B serum level predicts computed tomography findings after minor head injury. Journal of Trauma 2007;62: 1452-1456.
9. Stalnacke BM, Bjornstig U, Karlsson K, Sojka P. One-year followup of mild traumatic brain injury: post-concussion symptoms, disabilities and life satisfaction in relation to serum levels of S-100B and neurone-specific en olase in acute phase. Journal of Rehabilitation Medicine 2005;37:300-305.
10. de Kruijk JR, Leffers P, Menheere PP, Meerhoff S, Twijnstra A. S-100B and neuron-specific enolase in serum of mil d traumatic brain injury patients. A comparison with health controls. Acta Neurologica Scandinavica 2001;103:175-179.
11. Ingebritsen T, Romner B, Kongstad P, Langbakk B. Increased serum concentr ations of protein S-100 after minor head injury: A biochemical serum marker with prognostic value? Journal of Neurology, Neurosurgery & Psychiatry 1995;59:103-104.
12. Levin HS, O'Donnell VM, Grossman RG. The galveston orientation and amnesia test. A practical scale to assess cognition after head injury. Journal of Nervous & Mental Disease 1979;167: 675-684.
13. McDowell I, Newell C. Psychol ogical wellbeing. Measuring health. A guide to rating scales and questionnaires. 2nd ed. New York: Oxford University Press; 1996.
14. Reeves D, Kane R, Winter K, Goldstone A. Automated neuropsychological ass essment metrics (ANAM V3.11): Clinical and neurotoxicology subsets. New York: National Cognitive Recovery Foundation; 1995. Report nr NCRF-SR-95-01.
15. Kane RL, Roebuck-Spencer T, Short P, Kabat M, Wilken J. Identifying and monitoring cognitive deficits in clinical populations using automated neuropsychological assessment metrics (ANAM) tests. Archives of Clinical Neuropsychology 2007;22:S115-S126.
16. Dischi nger PC, Ryb GE, Kufera JA, Auman KM. Early predictors of postconcussive syndrome in a population of trauma patients with mild traumatic brain injury. Journal of Trauma 2009;66:289, 296; discussion 296-297.
17. Savola O, Pyhtinen J, Leino TK, Siitonen S, Niemela O, Hillbom M. Effects of head and extracranial injuries on serum protein S100B levels in trauma patients. Journal of Trauma 2004; 56:1229, 1234; discussion 1234.
18. Townend WJ, Guy MJ, Pani MA, Martin B, Yates DW. Head injury outcome prediction in the emergency department: A role for protein S-100B? Journal of Neurology, Neurosurgery & Psychiatry 2002; 73:542-546.
19. Stranjalis G, Korfias S, Papapetrou C, Kouyialis A, Boviatsis E, Psachoulia C, Sakas DE. Elevated serum S-100B protein as a predictor of failure to sho rt-term return to work or activities after mild head injury. Journal of Neurotrauma 2004;21:1070-1075.
20. Ingebritsen T, Waterloo K, Marup-Jensen S, Attner E, Romner B. Quantification of pos t-concussion symptoms 3 months after minor head injury in 100 consecutive patients. Journal of Neurology 1998; 245:609-612.
21. Martelli MF, Grayson RL, Zasler ND. Posttraumatic headache: Neuropsycho logical and psychological effects and treatment implications. Journal of Head Trauma Rehabilitation 1999;14:49-69.
22. Alexander MP. Mild traumatic brain injury: pathophysiology, natural history, and clinical management. Neurology 1995;45: 1253-1260.
23. Rothoerl RD, Woertgen C, Holzschuh M, Metz C, Brawanski A. S-100 serum levels after minor and major head injury. Journal of Trauma 1998;45:765-767.
24. Ingebrigtsen T, Romner B, Marup-Jensen S, Dons M, Lundqvist C, Bellner J, Alling C, Borgesen SE. The clinical value of serum S-100 protein measurements in minor head injury: A scandinavian multicentre study. Brain Injury 2000;1 4:1047-1055.
25. Wolf H, Frantal S, Pajenda GS, Salameh O, Widhalm H, Hajdu S, Sarahrudi K. Predictive value of neuromarkers supported by a set of clinical criteria in patients with mild traumatic b rain injury: S100B protein and neuron-specific enolase on trial: Clinical article. Journal of Neurosurgery 2013;118:1298-1303.
26. Bazarian JJ, Blyth BJ, He H, Mookerjee S, Jones C, Kiechle K , Moynihan R, Wojcik SM, Grant WD, Secreti LM, et al. Classification accuracy of serum apo A-I and S100B for the diagnosis of mild traumatic brain injury and prediction of abnormal initial head computed tomography scan. Journ al of Neurotrauma 2013;30:1747-1754.
27. Calcagnile O, Holmen A, Chew M, Unden J. S100B levels are affected by older age but not by alcohol intoxication following mild traumatic brain injury. Sca ndinavian Journal of Trauma, Resuscitation & Emergency Medicine 2013;21:52.
28. De Boussard NC,Fredman P,Lundin A,Andersson K,Edman G,Borg J. S100 in mild traumatic brain injury. Brain Injury. 2004;18:671-683.
29. Savola O, Hillbom M. Early predictors of post-concussion symptoms in patients with mild head injury. European Journal of Neurology 2003;10:175-181.
30. Stapert S, de Kruijk J, Houx P, Menheere P, Twijnstra A, Jolles J. S-100B concentration is not related to neurocognitive performance in the first month after mild traumatic brain injury. European Neurology 2005;53:22-26.
31. de Boussard CN, Lundin A, Karlstedt D, Edman G, Bartfai A, Borg J. S100 and cognitive impairment after mild traumatic brain injury. Journal of Rehabilitation Medicine 2005;37:53-57.
32. De Kruijk JR, Leffers P, Menheere PP, Meerhoff S, Rutten J, Twijnstra A. Prediction of post-traumatic complaints after mild traumatic brain injury: early symptoms and biochem ical markers. Journal of Neurology, Neurosurgery & Psychiatry 2002;73: 727-732.
33. Bazarian JJ, Zemlan FP, Mookerjee S, Stigbrand T. Serum S-100B and cleaved-tau are poor predictors of long- term outcome after mild traumatic brain injury. Brain Injury 2006;20:759-765.
34. Townend W, Dibble C, Abid K, Vail A, Sherwood R, Lecky F. Rapid elimination of protein S-100B from serum after minor head trauma. Journal of Neurotrauma 2006;23:149-155.